Skip to main content

Table 1 Demographic and clinical characteristics of the study participants at baseline and twelve weeks by mean (standard deviation)

From: Improvement in symptoms and signs in the forefoot of patients with rheumatoid arthritis treated with anti-TNF therapy

Variable

Baseline

12 weeks

Statistical Values

MFPDI (×/38)

23.17 (9.23)

17.13 (9.73)

t = 3.712, p = 0.001

VAS* (100 mm)

60.29 (21.12)

45.31 (23.25)

t = 2.735, p = 0.011

ESR (mm/hour)

37.86 (24.48)

26.5 (16.4)

t = 4.014, p < 0.001

CRP (mg/litre)

31.92 (27.15)

13.98 (15.38)

t = 3.889, p = 0.001

DAS-28

5.76 (0.93)

4.54 (1.5)

t = 3.712, p = 0.001

  1. *Overall well being